| Lumigan (bimatoprost) / Senju, AbbVie |
ACTRN12610000199011: Comparative Study of the Efficacy and Safety of two presentations of Bimatoprost 0.03% available in Brazil: Glamigan(registered trademark) and Lumigan(registered trademark). |
|
|
| Not yet recruiting | 4 | 54 | | | Ophthalmology Department of the State University of Campinas, Germed Pharma ltda | glacoma, ocular hypertension | | | | |
2013-000581-10: Examining the effects of eye drops on changes in inflammation on the surface of the eye |
|
|
| Ongoing | 4 | 100 | Europe | latanoprost, travaprost, bimatoprost, tafluprost, Timolol maleate, Brimonidine tartrate, Brinzolamide, Dorzolamide hydrochloride, pilocarpine hydrochloride, Pilocarpine nitrate, N/A, Eye drops, solution, Eye drops, , Xalatan, Travatan, Lumigan, Saflutan, Timptol, Trusopt, Pilocarpine hydrochloride, N/A | Nottingham University NHS Trust | Glaucoma is the condition that is being treated by these eye drops - however the study is aimed at measuring the amount of inflammation that develops on the surface of the eye when these drops are used, Diseases [C] - Eye Diseases [C11] | | | | |
2014-004442-10: Investigation of intraocular pressure and tolerability of Bimatoprost 0.1% and Tafluprost Unit Dose Preservative Free 15 microgram/ml. |
|
|
| Ongoing | 4 | 67 | Europe | Eye drops, solution, Eye drops, suspension in single-dose container, Preservatived Bimatoprost, Lumigan 0.1 mg/ml, Tafluprost Unit Dose Preservative Free | UZ Leuven, Allergan | Ocular hypertension and glaucoma, Ocular hypertension and glaucoma, Diseases [C] - Eye Diseases [C11] | | | | |
2014-000404-10: Effectiveness in the ocular pressure, tolerability and influence in the ocular surface of bimatoprost and tafluprost pod in patients with glaucoma and ocular hipertension Eficacia sobre la presión intraocular, tolerancia e influencia sobre la superficie ocular del Bimatoprost monodosis y Talfuprost monodosis en pacientes con glaucoma e hipertension ocular |
|
|
| Ongoing | 4 | 60 | Europe | Bimatoprost, Tafluprost, Eye drops | Hospital Clinico San Carlos, Allergan Inc | Glaucoma andr ocular hypertension Glaucoma e hipertension ocular, Ocular hypertension Tension ocular alta, Diseases [C] - Eye Diseases [C11] | | | | |
2010-024272-26: Comparison between the effects on ocular pressure of Bimatoprost 0.01% and Timolol 0.5% during the day and night Confronto tra gli effetti sulla pressione degli occhi del Bimatoprost 0.01% e Timololo 0.5% di giorno e di notte |
|
|
| Ongoing | 4 | 40 | Europe | LUMIGAN*COLL FL 3ML 0,1MG/ML, TIMOLOLO NOVARTIS*OFT 5ML 0,5%, LUMIGAN*COLL FL 3ML 0,1MG/ML, TIMOLOLO NOVARTIS*OFT 5ML 0,5% | IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS, Allergan | glaucoma and ocular hypertension glaucoma ed ipertensione oculare | | | | |
NCT06761313: Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma |
|
|
| Active, not recruiting | 4 | 40 | RoW | Triple combination formula, Maleate Timolol 0.5%, Brimonidine Tartarate 0.2%, Bimatoprost 0.03%, Bimatoprost .03% sterile ophthalmic solution, Timolol Maleate 0.5%, Brimonidine Tartarate 0.2%, Bimatoprost 0.03% | Federal University of São Paulo | Glaucoma, Quality of Life (QOL) | 12/24 | 02/25 | | |
| Recruiting | 4 | 48 | | Use bimatoprost ;Use travoprost ;Use latanprost ;Use tafluprost | West China Hospital of Sichuan University; West China Hospital of Sichuan University, 2019 West China Clinical Medical College of Sichuan University /West China Hospital Resident/Specialist Scientific Research Fund | Glaucoma | | | | |
NTG, NCT04981886: Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma |
|
|
| Not yet recruiting | 4 | 115 | US | Netarsudil Ophthalmic, Rhopressa, Bimatoprost Ophthalmic, Lumigan | Salus University | Normal Tension Glaucoma | 07/22 | 08/22 | | |
NCT06369077: How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? |
|
|
| Terminated | 4 | 36 | US | dorzolamide/timolol, latanoprost, timolol/brimonidine/dorzolamide/bimatoprost | CT Glaucoma Associates | Glaucoma, Open-Angle, Glaucoma; Drugs | 07/24 | 07/24 | | |
2010-020213-82: Comparison of Incidence and Severity of conjunctival hyperemia associated with use of topical Bimatoprost 0.01% and latanoprost 0.005% in Glaucoma or Ocular Hypertensive patients |
|
|
| Ongoing | 3 | 30 | Europe | lumigan 0.1, XALATAN, lumigan 0.1, XALATAN | IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | glaucoma or ocular hypertension | | | | |
2014-002553-19: Bimatoprost 0,3mg/ml- Eyedrops for lash-lenghtening - Pilot Study Bimatoprost 0,3mg/ml- Augentropfen zur Wimpernverlänngerung - Pilotstudie, Halbseitenversuch |
|
|
| Ongoing | 3 | 15 | Europe | Lumigan 0,3 mg/ml, Lumigan 0,3 mg/ml | Medizinische Universität Graz, Universitätsklinik für Dermatologie, Medizinische Universität Graz | women with too short lashes Frauen mit zu kurzen Wimpern | | | | |
NCT05401357: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. |
|
|
| Recruiting | 3 | 168 | US | Test - Bimatoprost 0.01% Ophthalmic Solution, Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) | Amneal Pharmaceuticals, LLC, CBCC Global Research | Glaucoma, Open-Angle, Ocular Hypertension | 12/22 | 12/22 | | |
NCT05397600: Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients |
|
|
| Completed | 3 | 684 | Canada, US, RoW | Bimatoprost Ophthalmic | Laboratoires Thea | Glaucoma, Ocular Hypertension | 03/24 | 03/24 | | |
| Completed | 3 | 500 | US | Latanoprost, Xalatan, Bimatoprost, Lumigan, Travoprost, Travatan, Timolol, Timoptic, Dorzolamide, Trusopt, Brinzolamide, Azopt, Acetazolamide, Diamox, Methazolamide, Neptazane | University of Miami, National Eye Institute (NEI) | Glaucoma | 10/24 | 10/24 | | |
| Recruiting | 2/3 | 20 | US | NCX 470, nitric oxide (NO)-donating bimatoprost prostaglandin analog, Placebo, Artificial tears | Nicox Ophthalmics, Inc. | Open Angle Glaucoma | 03/25 | 03/25 | | |
2017-002823-46: Efficacy and safety assessment of T4030 eye drops (unpreserved fixed combination of bimatoprost 0.01% and timolol 0.1% or 0.5%) versus Ganfort® UD (Unit Dose) in ocular hypertensive or glaucomatous patients. |
|
|
| Ongoing | 2 | 108 | Europe | Ganfort UD, Unpreserved fixed combination bimatoprost 0.01% and timolol 0.1% eye drops presented in unit dose, Unpreserved fixed combination bimatoprost 0.01% and timolol 0.5% eye drops presented in unit dose, T4030a, T4030c, Eye gel in single-dose container, Ganfort UD | Laboratoires THÉA; Research and Development Department, Laboratoires THÉA | Glaucoma, ocular hypertension, over tension in the eye, Body processes [G] - Ocular Physiological Phenomena [G14] | | | | |
NCT06122090: Treatment of Hypopigmented Scars With Bimatoprost |
|
|
| Recruiting | 2 | 25 | US | Bimatoprost, Saline | Medstar Health Research Institute, Latham Fund | Scars, Hypopigmented Scar, Hypopigmented Skin, Burn Scar, Scarring, Cicatrix, Hypertrophic, Cicatrix, Pigmentation Disorder, Burns Laser | 12/24 | 07/25 | | |
NCT04499248: AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension |
|
|
| Recruiting | 1/2 | 96 | Japan, US | AGN-193408 SR, Lumigan, Active Comparator, Sham Administration, Lumigan Vehicle, Vehicle | AbbVie | Open-angle Glaucoma, Ocular Hypertension | 08/28 | 08/28 | | |
NCT05729594: Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers |
|
|
| Completed | 1 | 40 | US | Bimatoprost Ophthalmic | Laboratoires Thea | Healthy Volunteers | 04/23 | 04/23 | | |
NCT06267274: A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes |
|
|
| Recruiting | 1 | 240 | US | Bimatoprost Ophthalmic Solution, 0.01%, LUMIGAN® (bimatoprost ophthalmic solution) 0.01% | Amneal Pharmaceuticals, LLC, CBCC Global Inc., Amneal EU, Limited | Open-angle Glaucoma, Ocular Hypertension | 03/25 | 05/25 | | |
NCT03708627: Bimatoprost as a Treatment for Graves' Orbitopathy |
|
|
| Recruiting | 1 | 3 | US | Bimatoprost Ophthalmic | Johns Hopkins University | Graves Ophthalmopathy | 07/28 | 07/30 | | |
NCT04896125: Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study |
|
|
| Recruiting | N/A | 300 | RoW | Lumigan PF; Xalatan | National Taiwan University Hospital | Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders) | 08/22 | 08/22 | | |
